why choose us

First received: November 19, 2024

Clinical Trial: A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Heart Failure

Study Type: INTERVENTIONAL


Official Title: Safety, Tolerability, and Pharmacokinetics of Single and Multiple Subcutaneous Injections of SHR-6934 in Healthy Subjects: a Randomized, Double-blind, Dose-escalation, Placebo-controlled Phase I Trial

Brief Summary: This study was a randomized, double-blind, single-dose and multi-dose, placebo-controlled phase ? clinical trial. Six dose groups were planned for the SAD part of the study and four dose groups were planned for the MAD part. A total of 88 healthy subjects were included.

Read more